BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15317586)

  • 1. Structural characterization of the human Nogo-A functional domains. Solution structure of Nogo-40, a Nogo-66 receptor antagonist enhancing injured spinal cord regeneration.
    Li M; Shi J; Wei Z; Teng FY; Tang BL; Song J
    Eur J Biochem; 2004 Sep; 271(17):3512-22. PubMed ID: 15317586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nogo goes in the pure water: solution structure of Nogo-60 and design of the structured and buffer-soluble Nogo-54 for enhancing CNS regeneration.
    Li M; Liu J; Song J
    Protein Sci; 2006 Aug; 15(8):1835-41. PubMed ID: 16877707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, solution conformation and identification of functional residues of the soluble and structured Nogo-54, which mimics Nogo-66 in inhibiting the CNS neurite outgrowth.
    Li M; Li Y; Liao X; Liu J; Qin H; Xiao ZC; Song J
    Biochem Biophys Res Commun; 2008 Sep; 373(4):498-503. PubMed ID: 18585367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N- and C-termini of the human Nogo molecules are intrinsically unstructured: bioinformatics, CD, NMR characterization, and functional implications.
    Li M; Song J
    Proteins; 2007 Jul; 68(1):100-8. PubMed ID: 17397058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and structural mechanism for a novel interaction between a ubiquitin ligase WWP1 and Nogo-A, a key inhibitor for central nervous system regeneration.
    Qin H; Pu HX; Li M; Ahmed S; Song J
    Biochemistry; 2008 Dec; 47(51):13647-58. PubMed ID: 19035836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Nogo-A in neuroregeneration: a review.
    Wang T; Xiong JQ; Ren XB; Sun W
    Brain Res Bull; 2012 Apr; 87(6):499-503. PubMed ID: 22414960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.
    GrandPré T; Nakamura F; Vartanian T; Strittmatter SM
    Nature; 2000 Jan; 403(6768):439-44. PubMed ID: 10667797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nogo-A functions during the development of the central nervous system and in the adult].
    Mingorance A; Soriano-García E; del Rio JA
    Rev Neurol; 2004 Sep 1-15; 39(5):440-6. PubMed ID: 15378458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of the myelin-derived nerve growth inhibitor Nogo-A.
    Schweigreiter R
    Neuron Glia Biol; 2008 May; 4(2):83-9. PubMed ID: 19737432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of the recombinant human Nogo-A ectodomain.
    Zander H; Hettich E; Greiff K; Chatwell L; Skerra A
    FEBS J; 2007 May; 274(10):2603-13. PubMed ID: 17437522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
    Chen MS; Huber AB; van der Haar ME; Frank M; Schnell L; Spillmann AA; Christ F; Schwab ME
    Nature; 2000 Jan; 403(6768):434-9. PubMed ID: 10667796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4.
    Oertle T; Huber C; van der Putten H; Schwab ME
    J Mol Biol; 2003 Jan; 325(2):299-323. PubMed ID: 12488097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No go for brain tumors?
    Teng FY; Tang BL
    J Mol Neurosci; 2005; 25(1):1-6. PubMed ID: 15781961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neurite Outgrowth Inhibitory Nogo-A-Δ20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity.
    Zelenay V; Arzt ME; Bibow S; Schwab ME; Riek R
    PLoS One; 2016; 11(9):e0161813. PubMed ID: 27611089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens.
    Hauben E; Ibarra A; Mizrahi T; Barouch R; Agranov E; Schwartz M
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15173-8. PubMed ID: 11752461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display.
    Schimmele B; Plückthun A
    J Mol Biol; 2005 Sep; 352(1):229-41. PubMed ID: 16061255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroscience. It takes more than two to Nogo.
    Woolf CJ; Bloechlinger S
    Science; 2002 Aug; 297(5584):1132-4. PubMed ID: 12183616
    [No Abstract]   [Full Text] [Related]  

  • 19. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.
    Pot C; Simonen M; Weinmann O; Schnell L; Christ F; Stoeckle S; Berger P; Rülicke T; Suter U; Schwab ME
    J Cell Biol; 2002 Oct; 159(1):29-35. PubMed ID: 12379801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a NEP1-35 recognizing peptide that neutralizes CNS myelin inhibition using phage display library.
    Deng Q; Cai W; Li S; Su B
    Neurosci Lett; 2013 Mar; 536():80-4. PubMed ID: 23352850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.